Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
and qualitative research insights. Job description Screen research articles based on the inclusion criteria Read and summarize academic papers Extract and record key study information Apply a structured
-
structures. By combining numerical modeling, laboratory experiments, and theoretical analyses, we seek to link microscopic processes with the macroscopic behavior of both engineering and natural systems and
-
driven by curiosity about the physical mechanisms that underlie failure and by the ambition to translate this understanding into more reliable and resilient materials and structures. By combining numerical
-
driven by curiosity about the physical mechanisms that underlie failure and by the ambition to translate this understanding into more reliable and resilient materials and structures. By combining numerical
-
The Institute of Molecular Systems Biology (IMSB) at ETH Zurich invites applications for a Postdoctoral Researcher in Metabolomics & Technology Development in the laboratory of Prof. Dr. Nicola
-
The Paul Scherrer Institute PSI is the largest research institute for natural and engineering sciences in Switzerland. We design, build and operate the country’s large-scale research infrastructures
-
their influence on film architecture on MEMS/miniaturized substrates Engineering and tailoring film architectures (thickness gradients, porosity/connectivity, hierarchical structures, multi-layer stacks
-
for diverse applications in the field of bio- and nano-technology. For this position, a project on the synthesis of imaging probes, targeting peptides and therapeutic molecules and covalent functionalization
-
of synthetic biodegradable polymers. These materials-ranging from structural to water-soluble polymers-are designed for complete microbial metabolic utilization in their intended receiving environments (e.g
-
, structural biology, and clinical research across Switzerland, Israel, Australia and the USA. The project Antibiotic treatments for M. abscessus fail in more than half of patients despite in vitro drug